| Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity AE O’Mara, JW Johnson, JD Linderman, RJ Brychta, S McGehee, ... The Journal of clinical investigation 130 (5), 2209-2219, 2020 | 285 | 2020 |
| COVID-19 vaccine hesitancy and attitude toward booster doses among US healthcare workers S Pal, R Shekhar, S Kottewar, S Upadhyay, M Singh, D Pathak, D Kapuria, ... Vaccines 9 (11), 1358, 2021 | 121 | 2021 |
| Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease JC Ravell, M Matsuda-Lennikov, SD Chauvin, J Zou, M Biancalana, ... The Journal of clinical investigation 130 (1), 507-522, 2020 | 88 | 2020 |
| A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis–end of study results from the LOWR HDV-3 study C Koh, P Surana, T Han, N Fryzek, D Kapuria, O Etzion, V Takyar, ... J Hepatol 66 (1), S101-S102, 2017 | 62 | 2017 |
| Association of hepatic steatosis with subclinical atherosclerosis: systematic review and meta‐analysis D Kapuria, VK Takyar, O Etzion, P Surana, JH O'Keefe, C Koh Hepatology communications 2 (8), 877-887, 2018 | 61 | 2018 |
| Fresh frozen plasma transfusion in acute variceal haemorrhage: Results from a multicentre cohort study A Mohanty, D Kapuria, A Canakis, H Lin, MJ Amat, G Rangel Paniz, ... Liver International 41 (8), 1901-1908, 2021 | 57 | 2021 |
| The spectrum of the deficiency of adenosine deaminase 2: an observational analysis of a 60 patient cohort KS Barron, I Aksentijevich, NT Deuitch, DL Stone, P Hoffmann, ... Frontiers in immunology 12, 811473, 2022 | 50 | 2022 |
| A phase 2 study of peginterferon lambda, lonafarnib and ritonavir for 24 weeks: end-of-treatment results from the LIFT HDV study C Koh, J Hercun, F Rahman, A Huang, B Da, P Surana, D Kapuria, ... Journal of Hepatology 73, S130, 2020 | 48 | 2020 |
| One world, one pandemic, many guidelines: management of liver diseases during COVID-19 S Bollipo, D Kapuria, A Rabiee, G Ben-Yakov, RN Lui, HW Lee, G Kumar, ... Gut 69 (8), 1369-1372, 2020 | 48 | 2020 |
| The spectrum of hepatic involvement in patients with telomere disease D Kapuria, G Ben‐Yakov, R Ortolano, MH Cho, OR Kalchiem‐Dekel, ... Hepatology 69 (6), 2579-2585, 2019 | 48 | 2019 |
| Liver-resident bystander CD8+ T cells contribute to liver disease pathogenesis in chronic hepatitis D virus infection H Kefalakes, XJ Horgan, MK Jung, G Amanakis, D Kapuria, FJ Bolte, ... Gastroenterology 161 (5), 1567-1583. e9, 2021 | 37 | 2021 |
| Portal pressure in noncirrhotic portal hypertension: to measure or not to measure BL Da, P Surana, D Kapuria, A Vittal, E Levy, DE Kleiner, C Koh, T Heller Hepatology 70 (6), 2228-2230, 2019 | 19 | 2019 |
| Early experience with COVID-19 patients at academic hospital in Southwestern United States R Shekhar, AB Sheikh, S Upadhyay, J Atencio, D Kapuria Infectious Diseases 52 (8), 596-599, 2020 | 17 | 2020 |
| Provider attitudes and practice patterns for direct-acting antiviral therapy for patients with hepatocellular carcinoma NE Rich, JD Yang, PV Perumalswami, N Alkhouri, W Jackson, ND Parikh, ... Clinical Gastroenterology and Hepatology 18 (4), 974-983, 2020 | 17 | 2020 |
| A PHASE 2 STUDY OF LONAFARNIB, RITONAVIR AND PEGINTERFERON LAMBDA FOR 24 WEEKS: INTERIM END-OF-TREATMENT RESULTS FROM THE LIFT HDV STUDY. C Koh, BL Da, P Surana, A Huang, D Kapuria, Y Rotman, A Vittal, ... Hepatology 70 (6), 1483A-1483A, 2019 | 16 | 2019 |
| Liver disturbances in activated phosphoinositide 3-kinase δ syndrome G Ben-Yakov, D Kapuria, J Marko, MH Cho, S Pittaluga, DE Kleiner, ... The journal of allergy and clinical immunology. In practice 6 (5), 1763, 2018 | 15 | 2018 |
| Diffuse large B-cell lymphoma causing acute liver failure: a rare case of survival D Kapuria, K Strasser, A Qasem Case Reports 2015, bcr2015209328, 2015 | 14 | 2015 |
| Cryptosporidium infection in dedicator of cytokinesis 8 (DOCK 8) deficiency GB Yakov, D Sharma, MH Cho, NN Shah, D Hickstein, A Urban, D Darnell, ... The journal of allergy and clinical immunology. In practice 8 (10), 3663, 2020 | 11 | 2020 |
| Roadmap to resuming care for liver diseases after coronavirus disease‐2019 D Kapuria, S Bollipo, A Rabiee, G Ben‐Yakov, G Kumar, K Siau, HW Lee, ... Journal of gastroenterology and hepatology 36 (4), 885-892, 2021 | 9 | 2021 |
| Characterization and timing of gastrointestinal bleeding in continuous flow left ventricular assist device recipients D Kapuria, T Khumri, S Shamim, P Surana, S Khan, N Al-Khalisi, ... Heliyon 6 (9), 2020 | 9 | 2020 |
Yaron RotmanNational Institutes of Health在 mail.nih.gov 的电子邮件经过验证
